1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. Massachusetts >
  6. Cadent Therapeutics

Cadent Therapeutics - Ownership and Business Overview

Life ScienceCompany

Cadent Therapeutics Ownership

Who owns Cadent Therapeutics?

Cadent Therapeutics is owned by Novartis AG. It was acquired on December 17, 2020.

Cadent Therapeutics Business Overview

Where is Cadent Therapeutics headquartered?

Cadent Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Cadent Therapeutics in?

Cadent Therapeutics is a life science company.

When was Cadent Therapeutics founded?

Cadent Therapeutics was founded in 2017.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Subscribe to Mergr to view all 297 acquisitions of life science companies in 2020, including 24 acquisitions by private equity firms, and 273 by strategics.

Cadent Therapeutics, Inc.

60 Hamilton St,
Cambridge, Massachusetts 02139
United States,
www.cadenttx.com

Cadent Therapeutics is a precision neuroscience company with a mission to discover and develop innovative treatments to restore brain rhythms and improve outcomes in patients living with movement, mood, and cognitive disorders. Currently in early clinical development, Cadent is rapidly advancing its pipeline of therapies to treat spinocerebellar ataxia, essential tremor, and schizophrenia. Cadent Therapeutics was formed in 2017 and is based in Cambridge, Massachusetts.


Company Summary

SECTOR

Life Science

Established

2017

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Cadent Therapeutics

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal